Literature DB >> 7302375

Styrene oxidation to styrene oxide in human blood erythrocytes and lymphocytes.

G Belvedere, F Tursi.   

Abstract

Human erythrocytes and lymphocytes catalyzed styrene oxidation to styrene oxide. The erythrocyte catalyzed reaction was inhibited by CO, occurred in the absence of NADPH and NADH and was undetectable in the absence of O2 and with erythrocyte membranes. Lymphocyte catalyzed styrene oxide formation required the addition of cofactors and these cells showed 6 times the activity of erythrocytes with a 4 times lower styrene concentration. Although lymphocytes appear to be more active than red blood cells in styrene oxidation, their contribution to styrene metabolism in whole blood seems extremely small.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7302375

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  3 in total

1.  Styrene oxidation to styrene oxide in human erythrocytes is catalyzed by oxyhemoglobin.

Authors:  F Tursi; M Samaia; M Salmona; G Belvedere
Journal:  Experientia       Date:  1983-06-15

2.  The Redox Potential of the β-93-Cysteine Thiol Group in Human Hemoglobin Estimated from In Vitro Oxidant Challenge Experiments.

Authors:  Federico Maria Rubino
Journal:  Molecules       Date:  2021-04-26       Impact factor: 4.411

3.  Modeling the antioxidant properties of the eye reduces the false-positive rate of a nonanimal eye irritation test (OptiSafe).

Authors:  Stewart J Lebrun; Sara Chavez; Roxanne Chan; Linda Nguyen; James V Jester
Journal:  Toxicol In Vitro       Date:  2021-06-30       Impact factor: 3.685

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.